How gallic acid regulates molecular signaling: role in cancer drug resistance
Nema prikaza
Autori
Hassani, SamiraGhanbari, Fahimeh
Lotfi, Marzieh
Alam, Waqas
Aschner, Michael
Popović-Djordjević, Jelena
Shahcheraghi, Seyed Hossein
Khan, Haroon
Članak u časopisu
Metapodaci
Prikaz svih podataka o dokumentuApstrakt
Cancer is one of the deadliest and most heterogeneous diseases. Cancers often develop drug resistance, which can lead to treatment failure or recurrence. Accordingly, anticancer compounds are essential for chemotherapy-resistant cancer cells. Phenolic compounds are of interest in the development of cancer drugs due to their medicinal properties and ability to target different molecular pathways. Gallic acid (GA), as one of the main components of phenol, which is abundantly present in plant compounds such as walnut, sumac, grapes, tea leaves, oak bark, and other plant compounds, has antitumor properties. GA can prevent cancer progression, cell invasion, and metastasis by targeting molecular pathways and is an effective complement to chemotherapy drugs and combating multidrug resistance (MDR). In this review, we discuss various mechanisms related to cancer, the therapeutic potential of GA, the antitumor properties of GA in various cancers, and the targeted delivery of GA with nanocarrier...s.
Ključne reči:
Antineoplastic Agents / Cancer / Drug resistance / Drug Resistance, Neoplasm / Gallic acid / Gallic Acid / Humans / Molecular pathway / Neoplasms / Signal TransductionIzvor:
Medical Oncology (Northwood, London, England), 2023, 40, 11, 308-Povezane informacije:
- Druga verzija
publishedVersion
Institucija/grupa
Poljoprivredni fakultetTY - JOUR AU - Hassani, Samira AU - Ghanbari, Fahimeh AU - Lotfi, Marzieh AU - Alam, Waqas AU - Aschner, Michael AU - Popović-Djordjević, Jelena AU - Shahcheraghi, Seyed Hossein AU - Khan, Haroon PY - 2023 UR - http://www.ncbi.nlm.nih.gov/pubmed/37755616 UR - http://aspace.agrif.bg.ac.rs/handle/123456789/6462 AB - Cancer is one of the deadliest and most heterogeneous diseases. Cancers often develop drug resistance, which can lead to treatment failure or recurrence. Accordingly, anticancer compounds are essential for chemotherapy-resistant cancer cells. Phenolic compounds are of interest in the development of cancer drugs due to their medicinal properties and ability to target different molecular pathways. Gallic acid (GA), as one of the main components of phenol, which is abundantly present in plant compounds such as walnut, sumac, grapes, tea leaves, oak bark, and other plant compounds, has antitumor properties. GA can prevent cancer progression, cell invasion, and metastasis by targeting molecular pathways and is an effective complement to chemotherapy drugs and combating multidrug resistance (MDR). In this review, we discuss various mechanisms related to cancer, the therapeutic potential of GA, the antitumor properties of GA in various cancers, and the targeted delivery of GA with nanocarriers. T2 - Medical Oncology (Northwood, London, England) T2 - Medical Oncology (Northwood, London, England)Med Oncol T1 - How gallic acid regulates molecular signaling: role in cancer drug resistance IS - 11 SP - 308 VL - 40 DO - 10.1007/s12032-023-02178-4 ER -
@article{ author = "Hassani, Samira and Ghanbari, Fahimeh and Lotfi, Marzieh and Alam, Waqas and Aschner, Michael and Popović-Djordjević, Jelena and Shahcheraghi, Seyed Hossein and Khan, Haroon", year = "2023", abstract = "Cancer is one of the deadliest and most heterogeneous diseases. Cancers often develop drug resistance, which can lead to treatment failure or recurrence. Accordingly, anticancer compounds are essential for chemotherapy-resistant cancer cells. Phenolic compounds are of interest in the development of cancer drugs due to their medicinal properties and ability to target different molecular pathways. Gallic acid (GA), as one of the main components of phenol, which is abundantly present in plant compounds such as walnut, sumac, grapes, tea leaves, oak bark, and other plant compounds, has antitumor properties. GA can prevent cancer progression, cell invasion, and metastasis by targeting molecular pathways and is an effective complement to chemotherapy drugs and combating multidrug resistance (MDR). In this review, we discuss various mechanisms related to cancer, the therapeutic potential of GA, the antitumor properties of GA in various cancers, and the targeted delivery of GA with nanocarriers.", journal = "Medical Oncology (Northwood, London, England), Medical Oncology (Northwood, London, England)Med Oncol", title = "How gallic acid regulates molecular signaling: role in cancer drug resistance", number = "11", pages = "308", volume = "40", doi = "10.1007/s12032-023-02178-4" }
Hassani, S., Ghanbari, F., Lotfi, M., Alam, W., Aschner, M., Popović-Djordjević, J., Shahcheraghi, S. H.,& Khan, H.. (2023). How gallic acid regulates molecular signaling: role in cancer drug resistance. in Medical Oncology (Northwood, London, England), 40(11), 308. https://doi.org/10.1007/s12032-023-02178-4
Hassani S, Ghanbari F, Lotfi M, Alam W, Aschner M, Popović-Djordjević J, Shahcheraghi SH, Khan H. How gallic acid regulates molecular signaling: role in cancer drug resistance. in Medical Oncology (Northwood, London, England). 2023;40(11):308. doi:10.1007/s12032-023-02178-4 .
Hassani, Samira, Ghanbari, Fahimeh, Lotfi, Marzieh, Alam, Waqas, Aschner, Michael, Popović-Djordjević, Jelena, Shahcheraghi, Seyed Hossein, Khan, Haroon, "How gallic acid regulates molecular signaling: role in cancer drug resistance" in Medical Oncology (Northwood, London, England), 40, no. 11 (2023):308, https://doi.org/10.1007/s12032-023-02178-4 . .